breast cancer, AI and NHS
NHS clinics will use artificial intelligence to screen for breast cancer in a massive “landmark” trial. Almost 700,000 ...
Novartis’ Kisqali (ribociclib) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat a ...
A major trial aiming to transform breast cancer screening with artificial intelligence has been launched, with almost 700,000 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results